Saudi Exchange's Pharmaceutical Sector Sees Significant Market Activity

The Saudi Exchange's Main Market witnessed substantial movement in the pharmaceutical sector, with key financial indicators revealing a notable shift in investor sentiments and the company's financial performance. As of August 27, 2025, the pharmaceutical company's share price closed at SAR 210.00, with a total of 597.64 million shares issued. The company's net income stood at SAR 3.57 billion, and its shareholders' equity reached SAR 17.03 billion. These developments reflect the dynamic nature of the pharmaceutical sector on the Saudi Exchange.

Key Takeaways:

The pharmaceutical company's closing price on August 27, 2025, was SAR 210.00, with 597.64 million shares issued.
The company's net income was reported at SAR 3.57 billion, with shareholders' equity amounting to SAR 17.03 billion.
The market cap for the company reached SAR 17.03 billion, comprising 0.20% of the market cap.
The earnings per share (EPS) stood at SAR 2.846, with a price-to-earnings ratio of 28.490.
The book value per share was reported at SAR 17.00, and the price-to-book value ratio was 4.77.
The company operates under the Main Market category, emphasizing its significance within the exchange.
The Big move in market cap underscores the changing investor sentiments and the company's financial performance.
The pharmaceutical sector's market cap demonstrated a noticeable movement, reflecting the dynamic nature of the market.

Statistics:

Market cap: SAR 17.03 billion
Closing price: SAR 210.00
Shares issued: 597.64 million
Net income: SAR 3.57 billion
Shareholders' equity: SAR 17.03 billion
Position in market cap: 0.20%
Earnings per share (EPS): SAR 2.846
Price-to-earnings ratio: 28.490
Book value per share: SAR 17.00
Price-to-book value ratio: 4.77

Sources:

Saudi Exchange's daily financial indicators, dated August 27, 2025
Saudi Exchange's Main Market listings and financial data